Dr Bernard Le Foll, MD PhD is a clinician-scientist specialized in drug addiction. He is Head of the Alcohol Research and Treatment Clinic and Head of the Translational Addiction Research Laboratory at the Centre for Addiction and Mental Health. He is an Associate Professor at University of Toronto in the Departments of Family and Community Medicine, Psychiatry, Pharmacology and Institute of Medical Sciences. Its clinical activity is centered on tobacco and alcohol dependence. He received specialized training in drug addiction and behavioral and cognitive therapy at Paris University in France. He has written the French smoking cessation guideline and has been coordinator of clinical trials in France and in Canada. He obtained a PhD in Pharmacology at INSERM and has performed a Fogarty Visiting Fellowship at the National Institutes of Health. His research evaluates novel therapeutic approaches using a combination of preclinical, clinical, genetic and brain imaging approaches. He has received scientific prizes and awards from the French Academy of Medicine, the American College for Neuropsychopharmacology, the College on Problems on Drug Dependence, the National Institutes of Health, the Society for Research on Nicotine and Tobacco, Pfizer, OPGRC, the Heart and Stroke Foundation, Ontario Lung Association, the Canadian Institutes for Health Research and NARSAD.